Research graph
References from Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower‐risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo‐controlled trial. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/evidoa2200008
10.1056/evidoa2200008 · External reference
10.1182/blood‐2009‐01‐200519
10.1182/blood‐2009‐01‐200519 · External reference
10.1101/cshperspect.a019505
10.1101/cshperspect.a019505 · External reference
10.1038/s41375‐022‐01613‐1
10.1038/s41375‐022‐01613‐1 · External reference
10.1016/j.redox.2020.101532
10.1016/j.redox.2020.101532 · External reference
10.1002/stem.493
10.1002/stem.493 · External reference
10.1016/j.stem.2011.10.005
10.1016/j.stem.2011.10.005 · External reference
10.1038/nature12362
10.1038/nature12362 · External reference
10.1073/pnas.73.10.3685
10.1073/pnas.73.10.3685 · External reference
10.1073/pnas.75.9.4538
10.1073/pnas.75.9.4538 · External reference
10.1056/nejm197909273011303
10.1056/nejm197909273011303 · External reference
10.1056/nejm198501173120301
10.1056/nejm198501173120301 · External reference
Inhibition of chemically induced morphological transformation and reversion of the transformed phenotype by ascorbic acid in C3H/10T 1/2 cells
1980 · External reference
10.1038/nature23876
10.1038/nature23876 · External reference
10.1073/pnas.1612262113
10.1073/pnas.1612262113 · External reference
10.1186/s13148‐019‐0739‐5
10.1186/s13148‐019‐0739‐5 · External reference
10.1182/blood‐2012‐03‐420489
10.1182/blood‐2012‐03‐420489 · External reference
10.1182/blood‐2016‐03‐643544
10.1182/blood‐2016‐03‐643544 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
External reference
Unresolved reference
2025 · External reference
Unresolved reference
2017 · External reference
10.1182/blood‐2016‐05‐714030
10.1182/blood‐2016‐05‐714030 · External reference
10.3390/nu15071657
10.3390/nu15071657 · External reference
10.5435/jaaosglobal‐d‐24‐00162
10.5435/jaaosglobal‐d‐24‐00162 · External reference
Unresolved reference
External reference
10.1097/hs9.0000000000000713
10.1097/hs9.0000000000000713 · External reference
10.1038/s41586‐018‐0125‐z
10.1038/s41586‐018‐0125‐z · External reference
10.1038/s41467‐023‐36906‐1
10.1038/s41467‐023‐36906‐1 · External reference
10.3390/nu16030383
10.3390/nu16030383 · External reference
10.1002/jlb.4ab0521‐243r
10.1002/jlb.4ab0521‐243r · External reference
10.1155/2014/426740
10.1155/2014/426740 · External reference
10.1016/j.cyto.2004.02.004
10.1016/j.cyto.2004.02.004 · External reference
10.1182/blood.2024024962
10.1182/blood.2024024962 · External reference
10.1186/s13148‐022‐01404‐6
10.1186/s13148‐022‐01404‐6 · External reference
10.1038/s41586‐022‐04785‐z
10.1038/s41586‐022‐04785‐z · External reference
10.1016/j.ccell.2023.04.006
10.1016/j.ccell.2023.04.006 · External reference
10.1056/nejmoa1408617
10.1056/nejmoa1408617 · External reference
10.1182/blood‐2017‐01‐763425
10.1182/blood‐2017‐01‐763425 · External reference
10.1016/j.pharmr.2025.100043
10.1016/j.pharmr.2025.100043 · External reference
10.1038/s42003‐020‐01220‐9
10.1038/s42003‐020‐01220‐9 · External reference
